As of June 30, 2026, JD HEALTH INTL INC. carries a market capitalization of 14.04B, placing it among publicly traded companies globally. Its enterprise value stands at 6.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 14.04B |
| Enterprise Value | 6.90B |
JD HEALTH INTL INC.'s next confirmed earnings release is scheduled for March 29, 2027.
| Earnings Date | 3/29/2027 |
As of June 30, 2026, JD HEALTH INTL INC. has 3.19B shares outstanding.
| Shares Outstanding | 3.19B |
These figures are as of June 30, 2026.
| PB Ratio | 1.55 |
| P/TBV Ratio | 1.60 |
As of June 30, 2026, JD HEALTH INTL INC. maintains a current ratio of 2.69, meaning it holds 2.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.69 |
| Quick Ratio | 2.28 |
| Debt / Equity | 1.42 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 5,263.00 |
As of the close on October 20, 2026, JD HEALTH INTL INC.'s stock has declined approximately 43.94% over the past 52 weeks.
| 52-Week Price Change | -43.94% |
| 50-Day Moving Average | 5.37 |
As of June 30, 2026, JD HEALTH INTL INC. holds 7.26B in cash and equivalents against 128.95M in total debt, resulting in a net debt position of -3.01B. Total book value stands at 9.06B, with working capital of 5.37B providing operational flexibility.
| Cash & Cash Equivalents | 7.26B |
| Total Debt | 128.95M |
| Net Debt | -3.01B |
| Equity (Book Value) | 9.06B |
| Book Value Per Share | 2.84 |
| Working Capital | 5.37B |
Already premium?